Biotech

All Articles

Lykos will talk to FDA to reexamine its own decision adhering to denial of MDMA therapy for post-traumatic stress disorder

.Adhering to an inadequate revealing for Lykos Rehabs' MDMA prospect for trauma at a latest FDA advi...

AN 2 halves census, quits phase 3 test after records disappoint

.AN2 Rehabs is reassessing its company in response to uninspired midphase data, swearing to lay off ...

Merck pays out $700M for bispecific, spying autoimmune opening and also possibility to challenge Amgen in cancer

.Merck &amp Co. is actually paying $700 million beforehand to challenge Amgen in a blood stream canc...

Gilead pays for J&ampJ $320M to exit licensing deal for seladelpar

.Along With Gilead Sciences on the verge of an FDA decision for its liver disease drug seladelpar, t...

' All hands on deck' at Lilly as peers target being overweight market

.CEO David Ricks can easily observe the firms establishing tents at basecamp responsible for Eli Lil...

Entero laying off personnel, abandoning workplace and also stopping R&ampD

.Cushion Liquidators has actually transformed Entero Rehabs white colored as a piece. The collector ...

Exelixis drops ADC after deciding it's no match for Tivdak

.Exelixis is giving up on its cells element (TF)- targeting antibody-drug conjugate after ending the...

Relay dislikes SHP2 prevention after Genentech leaves behind

.Three weeks after Roche's Genentech device left an SHP2 inhibitor treaty, Relay Therapeutics has ve...

Stoke's Dravet syndrome med launched of partial clinical hold

.Stoke Therapeutics' Dravet disorder medication has actually been without a predisposed hold, gettin...

Fierce Biotech's Gabrielle Masson shows Tough 15 at NYSE

.Brutal Biotech Affiliate Publisher Gabrielle Masson presented the 2024 lesson of Tough 15 champions...